⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8284153 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL15561475 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL2214173 | 0.96 | — | — | |
| SCHEMBL2267702 | 0.79 | — | — | |
| SCHEMBL38494 | 0.72 | — | — | |
| SCHEMBL11830007 | 0.72 | — | — | |
| SCHEMBL6586016 | 0.72 | — | — | |
| SCHEMBL9452502 | 0.69 | — | — | |
| SCHEMBL23139417 | 0.67 | — | — | |
| SCHEMBL1896095 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108822243-A | A kind of preparation and its application of N-heterocyclic carbine gold porous organic polymer | 华东师范大学 | 2018-11-16 | — | — | CN | claimed |
| US-12570648-B2 | 6,7-dihydro-5H-pyrido[2,3-c]pyridazine derivatives and related compounds as Bcl-xL protein inhibitors and pro-apoptotic agents for treating cancer | LES LABORATOIRES SERVIER (FR) | 2026-03-10 | — | — | US | disclosed |
| EP-3956033-B1 | BICYCLIC COMPOUNDS | VIVACE THERAPEUTICS INC (US) | 2024-12-11 | — | — | EP | disclosed |
| US-12103902-B2 | Bicyclic compounds | VIVACE THERAPEUTICS, INC. (US) | 2024-10-01 | — | — | US | disclosed |
| WO-2024129763-A1 | MODULATORS OF TNF-α ACTIVITY | FORWARD THERAPEUTICS, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| CN-114072207-B | Bicyclic compounds | 维瓦斯治疗公司 | 2024-03-29 | — | — | CN | disclosed |
| US-11866431-B2 | Bicyclic compounds | VIVACE THERAPEUTICS, INC. (US) | 2024-01-09 | — | — | US | disclosed |
| US-20230142119-A1 | TETRACYCLIC COMPOUND | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-05-11 | — | — | US | disclosed |
| WO-2023044046-A1 | BCL-XL DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2023-03-23 | — | — | WO | disclosed |
| US-20230061429-A1 | BICYCLIC COMPOUNDS | VIVACE THERAPEUTICS, INC. | 2023-03-02 | — | — | US | disclosed |
| WO-2004063198-A1 | DIAZEPINOINDOLE DERIVATIVES AS KINASE INHIBITORS | PFIZER INC. (US) | 2004-07-29 | — | — | WO | disclosed |
| US-20040097731-A1 | Hallogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1and tnf | NOVARTIS AG (CH) | 2004-05-20 | — | — | US | disclosed |
| EP-1379234-A1 | HALOGENATED AMINOBENZOPHENONES AND AMINOBENZOYLPYRIDINES AS INHIBITORS OF IL-1 AND TNF | Novartis AG (CH) | 2004-01-14 | — | — | EP | disclosed |
| WO-2002076447-A1 | HALLOGENATED AMINOBENZOPHENONES AND AMINOBENZOYLPYRIDINES AS INHIBITORS OF IL-1 AND TNF | NOVARTIS AG (CH) | 2002-10-03 | — | — | WO | disclosed |
| EP-0414180-A2 | Hydroxylated ene ketones, acetylenic grignards and hydroxylated yne ketones therefrom | MARION MERRELL DOW INC. (US) | 1991-02-27 | — | — | EP | disclosed |
| US-4973756-A | Hydroxylated ene ketones, acetylenic grignards and hydroxylated yne ketones therefrom | MARION LABORATORIES, INC. (US) | 1990-11-27 | — | — | US | disclosed |
| US-4622368-A | Plasticized polyetherimide blends | GENERAL ELECTRIC COMPANY (US) | 1986-11-11 | — | — | US | disclosed |
| US-4168319-A | FUNGICIDES | STAUFFER CHEMICAL COMPANY (US) | 1979-09-18 | — | — | US | disclosed |
| EP-0001721-A2 | N-cyano- and N-alkynyl-2-(substituted phenoxy)butyramides and the use thereof as mildewicides | STAUFFER CHEMICAL COMPANY (US) | 1979-05-02 | — | — | EP | disclosed |
| US-3933794-A | CENTRAL NERVOUS SYSTEM DEPRESSANTS | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |